[For or against the early use of nasal continuous positive pressure and exogenous surfactant in hyaline membrane disease. Physiopathologic arguments].
The use of nasal CPAP in the treatment of respiratory distress syndrome in very premature newborns follows pathophysiological basis. The authors emphasize the usefulness of nasal CPAP and surfactant in the treatment of respiratory distress syndrome. The aim of this strategy is to reduce alveolar atelectasis, thus reducing the incidence and the severity of respiratory distress syndrome, together with a possible reduction of the incidence of bronchopulmonary dysplasia.
Storme
L
L
Service de médecine néonatale, Hôpital Jeanne-de-Flandre, CHRU de Lille, France.
Truffert
P
P
Rakza
T
T
Lequien
P
P
D001997:Bronchopulmonary Dysplasia / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D006819:Hyaline Membrane Disease / Q000503:physiopathology / Q000628:therapy*; D007231:Infant, Newborn; D007234:Infant, Premature; D011175:Positive-Pressure Respiration; D011650:Pulmonary Alveoli / Q000503:physiopathology; D001261:Pulmonary Atelectasis / Q000503:physiopathology / Q000517:prevention & control; D011663:Pulmonary Surfactants / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000503:physiopathology / Q000517:prevention & control
D011663:Pulmonary Surfactants
Pour ou contre une utilisation précoce de la pression positive continue nasale et du surfactant exogène au cours de la maladie des membranes hyalines. Arguments physiopathologiques.